Scientific Session

Bispecific Antibodies: Design and Rationale

Virtual Speaker(s)

• PP

  Paul Parren, PhD

  LAVA Therapeutics
  Odijk, Netherlands

  Disclosure: Disclosure(s): No financial relationships with ineligible companies to disclose